Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

Quoc-Dien Trinh; Daniel J. George; Neal Shore; Egils Vjaters; David Olmos; Andrea Juliana P. de Santana Gomes; Augusto Cesar de Andrade Mota; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Kunhi Parambath Haresh; Fred Saad

doi:10.1097/01.JU.0001109908.15997.76.01

Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

Quoc-Dien Trinh
, Daniel J. George
, Neal Shore
, Egils Vjaters
, David Olmos
, Andrea Juliana P. de Santana Gomes
, Augusto Cesar de Andrade Mota
, Natasha Littleton
, Shankar Srinivasan
, Frank Verholen
, Kunhi Parambath Haresh
, Fred Saad

Research output: Contribution to journal › Meeting Abstract › peer-review

2 Downloads (Pure)

Original language	English
Article number	MP16-01
Pages (from-to)	e578
Number of pages	1
Journal	Journal of Urology
Volume	213
Issue number	5S Suppl.
DOIs	https://doi.org/10.1097/01.JU.0001109908.15997.76.01
Publication status	Published - May 2025
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

10.1097/01.JU.0001109908.15997.76.01

EFFICACY AND SAFETY OF DAROLUTAMIDE PLUSFinal published version, 96.9 KB

Cite this

Trinh, Q.-D., George, D. J., Shore, N., Vjaters, E., Olmos, D., Gomes, A. J. P. D. S., Mota, A. C. D. A., Littleton, N., Srinivasan, S., Verholen, F., Haresh, K. P., & Saad, F. (2025). Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial. Journal of Urology, 213(5S Suppl.), e578. Article MP16-01. https://doi.org/10.1097/01.JU.0001109908.15997.76.01

@article{a532361d106643baab60cdac77b43f9d,

title = "Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial",

author = "Quoc-Dien Trinh and George, \{Daniel J.\} and Neal Shore and Egils Vjaters and David Olmos and Gomes, \{Andrea Juliana P. de Santana\} and Mota, \{Augusto Cesar de Andrade\} and Natasha Littleton and Shankar Srinivasan and Frank Verholen and Haresh, \{Kunhi Parambath\} and Fred Saad",

year = "2025",

month = may,

doi = "10.1097/01.JU.0001109908.15997.76.01",

language = "English",

volume = "213",

pages = "e578",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "5S Suppl.",

}

Trinh, Q-D, George, DJ, Shore, N, Vjaters, E, Olmos, D, Gomes, AJPDS, Mota, ACDA, Littleton, N, Srinivasan, S, Verholen, F, Haresh, KP & Saad, F 2025, 'Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial', Journal of Urology, vol. 213, no. 5S Suppl., MP16-01, pp. e578. https://doi.org/10.1097/01.JU.0001109908.15997.76.01

Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial. / Trinh, Quoc-Dien; George, Daniel J.; Shore, Neal et al.
In: Journal of Urology, Vol. 213, No. 5S Suppl., MP16-01, 05.2025, p. e578.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

AU - Trinh, Quoc-Dien

AU - George, Daniel J.

AU - Shore, Neal

AU - Vjaters, Egils

AU - Olmos, David

AU - Gomes, Andrea Juliana P. de Santana

AU - Mota, Augusto Cesar de Andrade

AU - Littleton, Natasha

AU - Srinivasan, Shankar

AU - Verholen, Frank

AU - Haresh, Kunhi Parambath

AU - Saad, Fred

PY - 2025/5

Y1 - 2025/5

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:001467945600035&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1097/01.JU.0001109908.15997.76.01

DO - 10.1097/01.JU.0001109908.15997.76.01

M3 - Meeting Abstract

SN - 0022-5347

VL - 213

SP - e578

JO - Journal of Urology

JF - Journal of Urology

IS - 5S Suppl.

M1 - MP16-01

ER -

Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

UN SDGs

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this